Novalis LifeSciences logo

Novalis LifeSciences

North America, Virginia, United States, Hampton

Description

Novalis Lifesciences is a globally acting venture capital firm focused on breakthrough technologies in Life Science.

Investor Profile

Novalis LifeSciences has made 20 investments, with 0 in the past 12 months and 65% as lead.

Stage Focus

  • Series B (40%)
  • Series D (15%)
  • Series C (15%)
  • Post Ipo Equity (10%)
  • Series Unknown (10%)
  • Series A (5%)
  • Seed (5%)

Country Focus

  • United States (80%)
  • Belgium (10%)
  • The Netherlands (5%)
  • United Kingdom (5%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Analytics
  • Life Science
  • Medical Device
  • Agriculture
  • Health Diagnostics
  • Agtech
  • Chemical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Novalis LifeSciences frequently co-invest with?

Bill & Melinda Gates Foundation
North America, New York, United States, New York
Co-Investments: 2
Rabobank Food & Agri Innovation Fund
Europe, Utrecht, The Netherlands, Utrecht
Co-Investments: 2
Finistere Ventures
North America, California, United States, San Diego
Co-Investments: 4
Anterra Capital
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 4
Northpond Ventures
North America, Maryland, United States, Bethesda
Co-Investments: 5
Tao Capital Partners
North America, California, United States, San Francisco
Co-Investments: 2
iSelect Fund
North America, Missouri, United States, St Louis
Co-Investments: 2
Romulus Capital
North America, Massachusetts, United States, Cambridge
Co-Investments: 2
Germin8 Ventures
North America, Illinois, United States, Chicago
Co-Investments: 2
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 2

Which angels does Novalis LifeSciences often collaborate with?

KC
North America, United States
Shared Deals: 1
David R. Walt
North America, Massachusetts, United States, Boston
Shared Deals: 1
TG
Asia, United Arab Emirates
Shared Deals: 1
EB
North America, New York, United States, New York
Shared Deals: 1
JA
North America, Illinois, United States, Chicago
Shared Deals: 1

What are some of recent deals done by Novalis LifeSciences?

BlueWhale Bio

Philadelphia, Pennsylvania, United States

BlueWhale Bio is committed to advancing cell-based therapeutics through manufacturing innovation.

BiotechnologyManufacturing
SeedSep 7, 2023
Amount Raised: $18,000,000
Flywheel.io

Minneapolis, Minnesota, United States

Flywheel.io is a data management and analysis platform built specifically for scientists and the researcher's workflow.

AnalyticsCloud Data ServicesCloud ManagementData ManagementSoftware
Series DJun 3, 2023
Amount Raised: $54,000,000
Telesis Bio

San Diego, California, United States

Telesis Bio is a biotech company that empowers researchers with the tools to secure design, code, and create synthetic DNA and mRNA.

BioinformaticsBiotechnologyHealth Care
Post Ipo EquityMay 31, 2023
Amount Raised: $74,200,000
Animol Discovery

Boston, Massachusetts, United States

We are a biopharmaceutical company focused on identifying and developing next- generation antiparasitics and therapeutics.

Biotechnology
Series BApr 17, 2023
Amount Raised: $9,150,000
Mercy BioAnalytics

Natick, Massachusetts, United States

Mercy BioAnalytics is a biotechnology company that aims to improve and save the lives of people through the early detection of cancer.

BiotechnologyHealth CareLife ScienceTherapeutics
Series AApr 3, 2023
Amount Raised: $41,000,000
LevitasBio

San Francisco, California, United States

LevitasBio is advancing science and human health by providing researchers with a new and powerful method of cellular analysis.

AnalyticsBiotechnologyHealth DiagnosticsTherapeutics
Series COct 24, 2022
Amount Raised: $35,000,000
etherna immunotherapies

Niel, Antwerpen, Belgium

etherna develops mRNA and lipid nanoparticle solutions.

BiotechnologyHealth CareMedical DeviceTherapeutics
Series BAug 23, 2022
Amount Raised: $38,869,747
Animol Discovery

Boston, Massachusetts, United States

We are a biopharmaceutical company focused on identifying and developing next- generation antiparasitics and therapeutics.

Biotechnology
Series BJul 28, 2022
Amount Raised: $34,000,000
Enko Chem, Inc.

Mystic, Connecticut, United States

Enko Chem utilizes predictive analytics to develop products for farmers that protect their crops from pests and disease.

AgricultureAgTechAnalyticsBiotechnologyChemical
Series CJul 27, 2022
Amount Raised: $70,000,000
Vizgen

Cambridge, Massachusetts, United States

Vizgen is a biotech company that develops solutions for next-generation spatially resolved, single-cell transcriptomics.

BiotechnologyHealth CareLife ScienceMedical
Series CJun 3, 2022
Amount Raised: $85,200,000